Free Trial

Avenue Therapeutics (ATXI) Insider Trading & Ownership

Avenue Therapeutics logo
$0.53 -0.02 (-3.67%)
As of 10:53 AM Eastern

Avenue Therapeutics (NASDAQ:ATXI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.60%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$552.26K
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$136.64
Get ATXI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avenue Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATXI Insider Buying and Selling by Quarter

Avenue Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/5/2024
Jay D Kranzler
Director
Sell61$2.24$136.64  
9/8/2023
Fortress Biotech, Inc.
Major Shareholder
Buy5,578$54.00$301,212.00  
9/8/2023
Lindsay A Md Rosenwald
Director
Buy4,649$54.00$251,046.00  
(Data available from 1/1/2013 forward)

ATXI Insider Trading Activity - Frequently Asked Questions

The list of insiders at Avenue Therapeutics includes Fortress Biotech, Inc., Jay D Kranzler, and Lindsay A Md Rosenwald. Learn more on insiders at ATXI.

8.60% of Avenue Therapeutics stock is owned by insiders. Learn more on ATXI's insider holdings.

The following insider sold ATXI shares in the last 24 months: Jay D Kranzler ($136.64).

Insiders have sold a total of 61 Avenue Therapeutics shares in the last 24 months for a total of $136.64 sold.



This page (NASDAQ:ATXI) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners